Please provide your email address to receive an email when new articles are posted on . Patients with cancer cachexia assigned ponsegromab gained significantly more weight than those assigned placebo.
Researchers from Canada’s McGill University have developed a potential tool that can detect early signs of cachexia in cancer patients, which could impact survival. Cancer cachexia is a phenomenon ...
Scientists at São Paulo State University (UNESP) in Brazil, along with colleagues from the University of Southern Denmark, and the University of Antioquia’s Medical School in Colombia, say they have ...
Dublin, Nov. 14, 2025 (GLOBE NEWSWIRE) -- The "Cancer Cachexia - Pipeline Insight, 2025" has been added to ResearchAndMarkets.com's offering. The "Cancer Cachexia - Pipeline Insight, 2025" report ...
The "Cancer Cachexia - Pipeline Insight, 2025" has been added to ResearchAndMarkets.com's offering. The report delivers in-depth analysis of over 15 companies and 20 pipeline drugs in the cancer ...
Olanzapine or dexamethasone, with 5-HT3 receptor antagonist and NK-1 receptor antagonist, to prevent nausea and vomiting induced by cisplatin-based doublet chemotherapy: A non-inferiority, prospective ...
Nutrition plays a crucial role in the lives of people with cancer. But more than a million people suffering from the disease in the United States also endure a wasting syndrome called cachexia.
Cachexia is one of the most common metabolic syndromes in patients with advanced cancer and is associated with decreased physical function, suboptimal treatment outcomes, compromised quality of life, ...
Cachexia interventions: - A cohort study followed by phase II and III studies should be undertaken in people with pancreatic cancer and cachexia or pre-cachexia, to compare cachexia assessment methods ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback